GSK to Acquire Asthma Drug Owner Aiolos for up to $1.4 Bn January 10, 2024 As per the deal, GSK will pay $1 billion upfront and up to $400 million in certain success-based regulatory milestone payments to Aiolos.
Page 1 of 1
Becton Dickinson in Talks with Thermo Fisher, Danaher for Life Sciences Unit Sale
XRHealth Acquires Innerworld to Expand Medical XR Mental Health Services
Epic Expands Beyond EHR with New AI & ERP Tools at HIMSS’25
Able Digital Wellness Raises $400K to Expand Disability Health-Tech Platform
athenahealth to Embed Microsoft Dragon Copilot in EHR
Fischer Medical Subsidiary to Supply 250 AI-Enabled Portable X-Ray Systems to Indonesia
Sign In & Stay updated with the latest news and analysis
+91
Or
sign in with
Sign in with google